CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 



Enzo Biochem Inc  (ENZ)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 
 

Enzo Biochem Inc Growth Comparisons

Select each growth Category to receive further Information

Select the Comparisons : Select the Ratio:                        

ENZ Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 6.92 % -66.41 % 24.81 % -1.85 %
Q / Q Revenue Growth (Q4 MRQ) -0.09 % -68.9 % -0.27 % 2.49 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 6.2 % -3.72 % 23.68 % -2.77 %
Seq. Revenue Growth (for 12 months ending Q4 TTM) 1.64 % -10.31 % 4.21 % 0.32 %
Revenue 5 Year Average Growth - 11.69 % 9.77 % 14.11 %
Expected Revenue Growth (Y/Y) - - 1.89 % 2.7 %


ENZ's Growth Comparisons in II. Quarter 2017


You need to upgrade your Flash Player


Enzo Biochem Inc managed to grow Revenue by 6.92% year on year, in the second quarter 2017 to 26 millions, while Medical Laboratories industry fell by -66.41%, Healthcare sector increased 24.81%. Although Medical Laboratories industry's Sales were softer then -1.85% overall market growth, Enzo Biochem Inc and the Healthcare sector have delivered above average market Sales.

Top-line fell by -0.09% from the first quarter. Average annual sales growth for Enzo Biochem Inc is %, while S & P 500's average yearly sales increase is 14.11%, including only Businesses with the second quarter 2017 financial results.


Growth Rates of ENZ's Income in the second quarter 2017


ENZ Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - - 263.89 % 48.84 %
Seq. Operating Income Change (Q4 MRQ) - - -21.44 % -7.47 %
Y / Y Operating Income Growth (Q4 TTM) 82.82 % -18.64 % 10.26 % 6.13 %
Seq. Operating Income Growth (Q4 TTM) -20.6 % -24.3 % 16.77 % 3.31 %
Operating Income 5 Year Avg. Change - 3.31 % -0.85 % 13.2 %

Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - - -24.93 % 26.44 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) - - -31.67 % -1.52 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) 87.45 % -40.73 % 1.85 % 7.94 %
Seq. Income from Cont. Ops. Change (Q4 TTM) -20.02 % -47.73 % -0.5 % 6.15 %
Income from Cont. Ops. 5 Year Avg. Change - -6.81 % 1.3 % 15.41 %

ENZ Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - - 5.95 % 34.03 %
Q / Q Net Income Growth (Q4 MRQ) - - -25.58 % 0.91 %
Y / Y Net Income Change (Q4 TTM) 87.45 % -81.01 % 11.81 % 10.77 %
Seq. Net Income Change (Q4 TTM) -20.02 % -83.33 % 0.73 % 6.24 %
Net Income 5 Year Avg. Growth - -6.59 % 4.53 % 15.39 %

ENZ's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - - -24.93 % 26.44 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) - - -31.67 % -1.52 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) 82.44 % - - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) -19.98 % - - 14.29 %
EPS from Cont. Ops. 5 Year Avg. Growth - -31.86 % 1.3 % 15.41 %

You need to upgrade your Flash Player

ENZ EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - - 5.95 % 15.41 %
Q / Q EPS Net Growth (Q4 MRQ) - - -25.58 % 0.91 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 22.01 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) -20.46 % - - 13.31 %
EPS Net 5 Year Avg. Change - -6.59 % 4.53 % 15.39 %
Expected EPS Growth (Y/Y) - - 123.59 % 27.58 %



Enzo Biochem Inc reported bottom-line of $ -0.02 in the second quarter, compare to $ 0.15 in the same quarter a year ago. Medical Laboratories industry fell by -66.41%, while Healthcare sector increased by 5.95%, and overall market improved by 34.03%.

Bottom-line fell by -0.09% from the first quarter. Average annual income per share growth for Enzo Biochem Inc is %, while S & P 500's average yearly income per share increase is 15.39%, including only Businesses with the second quarter 2017 earnings.

ENZ Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) - 270.77 % 31.08 % 23.33 %
Seq. Free Cash Flow Change (Q4 MRQ) - 97.89 % 24.16 % 58.36 %
Y / Y Free Cash Flow Change (Q4 TTM) 53.66 % 77.14 % 10.43 % -5.47 %
Seq. Free Cash Flow Change (Q4 TTM) -23.23 % 21.81 % 5.56 % 1.81 %
Free Cash Flow 5 Year Avg. Change - 6.16 % 5.19 % 15.98 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - - 1505.17 % -
Seq. Net Cash Flow Change (Q4 MRQ) - -81.96 % - -
Y / Y Net Cash Flow Change (Q4 TTM) 21.31 % 66.51 % 145.91 % 491.52 %
Seq. Net Cash Flow Change (Q4 TTM) - -4.69 % - -30.27 %
Net Cash Flow 5 Year Avg. Change - - -17.47 % 25.68 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) -60.05 % -0.41 % -6.24 % 10.57 %
Seq. Capital Expenditures Change (Q4 MRQ) -65.95 % -6.52 % 38.58 % 35.44 %
Y / Y Capital Expenditures Change (Q4 TTM) -44.08 % 30.29 % 6.03 % -8.35 %
Seq. Capital Expenditures Change (Q4 TTM) -17.09 % 15.25 % 0.54 % 4.72 %
Capital Expenditures 5 Year Avg. Change - - - -

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com